Development of radiocontrast agents for vascular imaging: Progress to date

American Journal of Cardiovascular Drugs

Volumn 2, Issue 6, 2002, Pages 357-365

  Blankenberg, Francis G ^a   Mari, Carina ^a   Strauss, H Williams ^b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CONTRAST MEDIUM; DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE F 18; INTEGRIN; IODINE 125; LIGAND; LIPOCORTIN 5; LIPOCORTIN 5 TC 99M; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 I 125; PENTETREOTIDE IN 111; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROMATOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BLOOD VESSEL; BLOOD VESSEL INJURY; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG TOLERABILITY; EPITHELIUM CELL; HUMAN; INFLAMMATION; INTRAVASCULAR CATHETER; ISOTOPE LABELING; MACROPHAGE; METABOLIC ACTIVATION; MONOCYTE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DETECTOR; RECEPTOR BINDING; RETROSPECTIVE STUDY; REVIEW; SAMPLING; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANNEXIN A5; ARTERIOSCLEROSIS; BLOOD VESSELS; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRIN ALPHAVBETA3; MUSCLE, SMOOTH, VASCULAR; RADIOISOTOPES; RADIONUCLIDE ANGIOGRAPHY; RADIOPHARMACEUTICALS; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036952780     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200202060-00001     Document Type: Review

References (108)

1. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-75
2. Kolodgie FD, Narula J, Burke AP, et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 2000; 157: 1259-68
3. Kolodgie FD, Narula J, Haider N, et al. Apoptosis in atherosclerosis: does it contribute to plaque instability? Cardiol Clin 2001; 19: 127-39
4. Kolodgie FD, Burke AP, Farb A, et al. The thin-cap fibroatheroma: a type of vulnerable plaque. The major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285-92
5. Boyle JJ, Bowyer DE, Weissberg PL, et al. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol 2001; 21: 1402-7
6. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile therosclerosis from the pathobiological determinants of atherosclerosis in youth (PDAY)-study. Atherosclerosis 2002; 160: 441-8
7. Nakajima T, Schulte S, Warrington KJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105: 570-5
8. Saxena A, McMeekin JD, Thomson DJ. Expression of Bcl-x, Bcl-2, Bax, and Bak in endarterectomy and atherectomy specimens. J Pathol 2002; 196: 335-42
9. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 2002; 15: 1-20
10. Becker AE, de Boer OJ, van derWal AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med 2001; 52: 289-97
11. Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 2002; 9: 425-32
12. Fortun A, Khalil A, Gagne D, et al. Monocytes influence the fate of T cells challenged with oxidized low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001; 156: 11-21
13. Burke AP, Farb A, Kolodgie FD, et al. Atherosclerotic plaque morphology and coronary thrombi. J Nucl Cardiol 2002; 9: 95-103
14. Iida KT, Suzuki H, Sone H, et al. Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2002; 22: 380-6
15. Gurfinkel E. Link between intracellular pathogens and cardiovascular diseases. Clin Microbiol Infect 1998; 4 Suppl. 4: S33-6
16. Cipollone F, Prontera C, Pini B, et al. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E (2)-dependent plaque instability. Circulation 2001; 104: 921-7
17. Zhu B, Reardon CA, Getz GS, et al. Both apolipoprotein e and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler Thromb Vasc Biol 2002; 22: 450-5
18. Virmani R, Burke AP, Farb A. Sudden cardiac death. Cardiovasc Pathol 2001; 10: 211-8
19. Libby P. What have we learned about the biology of atherosclerosis?: the role of inflammation. Am J Cardiol 2001; 88: 3J-6J
20. Takano M, Mizuno K, Okamatsu K, et al. Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001; 38: 99-104
21. Naghavi M, Madjid M, Raza Khan M, et al. New developments in the detection of vulnerable plaque. Curr Atheroscler Rep 2001; 3: 125-35
22. Narula J, Virmani R, Iskandrian AE. Strategic targeting of atherosclerotic lesions. J Nucl Cardiol 1999; 6: 81-90
23. Uehara A, Isaka Y, Hashikawa K, et al. Iodine-131-labeled fibronectin: a potential agent for imaging atherosclerotic lesions and thrombus. J Nucl Med 1988; 29: 1264-7
24. Finklestein S, Miller A, Callahan RJ, et al. Imaging of acute arterial injury with 111In labeled platelets: a comparison with scanning electron micrographs. Radiology 1982 Oct; 145 (1): 155-9
25. Davis HH, Siegel BA, Sherman LA, et al. Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation 1980; 61: 982-8
26. Park JH, Bettmann MA, Adelman B, et al. In vivo imaging and evaluation of platelet accumulation vs time at arterial injury site. Invest Radiol 1985; 20: 287-92
27. Thakur ML, DeFulvio J. Radiolabeled antibodies specific for human blood elements. Prog Clin Biol Res 1990; 355: 281-92
28. Lister-James J, Knight LC, Maurer AH, et al. Thrombus imaging with a technetium-99m-labeled activated platelet receptor-binding peptide. J Nucl Med 1996; 37: 775-81
29. Lees RS, Lees AM, Strauss HW. External imaging of human atherosclerosis. J Nucl Med 1983; 24: 154-6
30. Roberts AB, Lees AM, Lees RS, et al. Selective accumulation of low density lipoproteins in damaged arterial wall. J Lipid Res 1983 Sep; 24 (9): 1160-7
31. Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labeled oxidized LDL in man. Atherosclerosis 1996; 126: 131-41
32. Hardoff R, Braegelmann F, Zanzonico P, et al. External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. J Clin Pharmacol 1993; 33: 1039-47
33. Fischman AJ, Rubin RH, Shaw BA, et al. Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobin. J Nucl Med 1989; 30: 1095-100
34. Demacker PN, Dormas TP, Koenders EB, et al. Evaluation of idium-111-polyclonal immunoglobin G to quantitate atherosclerosis in Watanabe heritbale hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethylestradiol. J Nucl Med 1993; 34: 1316-21
35. Narula J, Petrov A, Ditlow C, et al. Maximizing radiotracer delivery of experimental atherosclerotic lesions with high dose negative charge-modified Z2D3 antibody for immunescintigraphic targeting. J Nucl Cardiol 1997; 4: 226-33
36. Carrio I, Pieri PL, Narula J, et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol 1998; 5: 551-7
37. Palac RT, Gray LL, Turner FE, et al. Detection of experimental atherosclerosis with indium-111 radiolabeled hematoporphyrin derivative. Nucl Med Commun 1989; 10: 841-50
38. Elmaleh DR, Narula J, Babich JW, et al. Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci U S A 1998; 95: 691-5
39. Strauss HW. Z2D3 imaging: fringe or frontier? J Nucl Cardiol 1998; 5: 626-8
40. Rosenfeld MA, Blessing E, Lin TM, et al. Chlamydia, inflammation, and atherogenesis. J Infect Dis 2000; 181 Suppl. 3: S492-7
41. Antony VB, Godbey SW, Kunkel SL, et al. Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993; 151: 7216-23
42. Rollins BJ. Monocyte chemoattractant protein-1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996; 2: 198-204
43. Valente AJ, Graves GT, Vialle-Valentin CE, et al. Purification of monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988; 27: 4162-8
44. Matsushima K, Larsen CG, DuBois GC, et al. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-90
45. Robinson E, Keystone EC, Schall TJ, et al. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398-407
46. Kurihara T, Warr G, Loy J, et al. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor, J Exp Med 1997; 186: 1757-62
47. Yoshimura T, Robinson EA, Tanaka S, et al. Purification and amino acid analysis of two human glioma derived monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J Immunol 1989; 142: 1956-62
48. Rattan V, Shen Y, Sultana C, et al. Diabetic RBC-induced oxidant stress leads to transendothelial migration of monocyte-like HL-60 cells. Am J Physiol 1997; 273: E369-75
49. Kunt T, Forst T, Fruh B, et al. Binding of monocytes from normolipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endrocrinol Diabetes 1999; 107: 252-6
50. Tsao PS, Niebauer J, Buitrago R, et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arteroscler Thromb Vasc Biol 1998; 18: 947-53
51. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion. Arteroscler Thromb Vasc Biol 1998; 18: 723-31
52. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9
53. Yu X, Dluz S, Graves DT, et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci U S A 1992; 89: 6953-7
54. Turner SJ, Domin J, Waterfield MD, et al. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J Biol Chem 1998; 273: 25987-95
55. Blankenberg FG, Tait JF, Blankenberg TA, et al. Imaging macrophages and the apoptosis of granulocytes in a rodent model of subacute and chronic abscesses with radiolabeled monocyte chemotactic peptide-1 and annexin V. Eur J Nucl Med 2001; 28: 1384-93
56. Ohtsuki K, Hayase M, Akashi K, et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001; 104: 203-8
57. Blankenberg FG, Wen P, Dai M, et al. Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabeteic Zucker rats. Pediatr Radiol 2001; 31: 827-35
58. Makimattila S, Luoma JS, Yla-Herttuala S, et al. Autoantibodies against oxidized LDL and endothelium-dependent vasodilation in insulin-dependent diabetes mellitus. Atherosclerosis 1999; 147: 115-22
59. Aparici CM, Narula J, Puig M, et al. Somatostatin receptor scintigraphy predicts impending cardiac allograft rejection before endomyocardial biopsy. Eur J Nucl Med 2000; 27: 1754-9
60. Breeman WA, de Jong M, Kwekkeboom DJ, et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 2001; 28: 1421-9
61. Vallabhajosula S, Moyer BR, Lister-James J, et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 1996; 37: 1016-22
62. Blum J. Receptor radiopharmaceuticals: biomolecular nuclear medicine. Eur J Nucl Med 2000; 27: 121-2
63. Reichlin S. Somatostatin. N Engl J Med 1983; 309: 1495-501
64. Cascini GL, Cuccurullo V, Rambaldi PF, et al. Immunological imaging using marked octreotide. Minerva Endocrinol 2001; 26: 129-33
65. Nocaudie M, Bailliez A, Itti E, et al. Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. Eur J Nucl Med 1999; 26: 511-7
66. Balon HR, Goldsmith SJ, Siegal BA, et al. Procedure guideline for somatostatin receptor scintigraphy with 111In-pentetreotide. J Nucl Med 2001; 42: 1134-8
67. Mari C, Nedelman M, Blankenberg F, et al. Detection of active atheroma in a rabbit model: evaluation of 8 radiotracers [abstract]. J Nucl Med 2001; 42 (5 Suppl.): 45P
68. Zinn KR, Buchsbaum DJ, Chaudhuri TR, et al. Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re. J Nucl Med 2000; 41: 887-95
69. Backer MV, Aloise R, Przekop K, et al. Molecular vehicles for targeted drug delivery. Bioconjug Chem 2002; 13: 462-7
70. Zhao Q, Egashira K, Inoue S, et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002; 105: 1110-5
71. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Nat Acad Sci U S A 1998; 95: 6349-54
72. Lahorte C, Slegers G, Philippe J, et al. Synthesis and in vitro evaluation of 123 I-labelled human recombinant annexin V. Biomol Eng 2001; 17: 51-3
73. Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001; 7: 1347-52
74. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356: 209-12
75. Post AM, Katsikis PD, Tait JF, et al. Imaging cell death with radiolabeled annexin v in an experimental model of rheumatoid arthritis. J Nucl Med 2002; 43 (10): 1359-65
76. Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-71
77. Zhang SH, Reddick RL, Burkey B, et al. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein e gene disruption. J Clin Invest 1994; 94: 937-45
78. Blankenberg FG, Eckelman WC, Strauss HW, et al. Role of radionuclide imaging in trials of antiangiogenic therapy. Acad Radiol 2000; 7: 851-67
79. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 2001; 52: 372-86
80. Yamani MH, Masri CS, Ratliff NB, et al. The role of vitronectin receptor (alpha v beta3) and tissue factor in the pathogenesis of transplant coronary vasculopathy. J Am Coll Cardiol 2002; 39: 804-10
81. Bishop GG, McPherson JA, Sanders JM, et al. Selective alpha (v) beta (3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 2001; 103: 1906-11
82. Dufourcq P, Louis H, Moreau C, et al. Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 1998; 18: 168-76
83. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A 1994; 91: 8856-60
84. Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 1157-64
85. Brooks PC, Stromblad S, Klemke R, et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995; 96: 1815-22
86. Ruoslahti E, Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest 1997; 100: S53-6
87. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264: 569-71
88. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542-6
89. Gurrath M, Muller G, Kessler H, et al. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Eur J Biochem 1992; 210: 911-21
90. Pfaff M, Tangemann K, Muller B, et al. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem 1994; 269: 20233-8
91. Haubner R, Westner HJ, Burkhart K, et al. Glycosylated RGD-containing peptides: tracer for tumor imaging and angiogenesis imaging with improved biokinetics. J Nucl Med 2001; 42: 326-36
92. Haubner R, Wester HJ, Reuning U, et al. Radiolabeled alpha (v) beta 3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999; 40: 1061-71
93. Haubner R, Wester HJ, Weber WA, et al. Noninvasive imaging of alpha (v) beta 3 integrin expression using 18F0labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001; 61: 1781-5
94. Su ZF, Liu G, Gupta S, et al. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD as a specific marker of alpha (V) beta (3) integrin for tumor imaging. Bioconjug Chem 2002 May-Jun; 13 (3): 561-70
95. Ziegler SI, Pichler BJ, Boening G, et al. A prototype high-resolution animal positron tomograph with avalanche photodiode arrays and LSO crystals. Eur J Nucl Med 2001; 28: 136-43
96. Paulus MJ, Gleason SS, Kennel SJ, et al. High resolution x-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2000; 2: 62-70
97. Guzman R, Lovblad KO, Meyer M, et al. Imaging the rat brain on a 1.5 T clinical MR-scanner. J Neurosci Methods 2000; 97: 77-85
98. Weber S, Terstegge A, Herzog H, et al. The design of an animal PET: flexible geometry for achieving optimal spatial resolution or high sensitivity. IEEE Trans Med Imaging 1997; 16: 684-9
99. Chatziioannou AF, Cherry SR, Shao Y, et al. Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med 1999; 40: 1164-75
100. Habraken JB, de Bruin K, Shehata M, et al. Evaluation of high-resolution pinhole SPECT using a small rotating animal. J Nucl Med 2001; 42: 1863-9
101. Iwata K, MacDonald LR, Hwang AB, et al. CT-SPECT for small animal imaging with the A-SPECT system [abstract]. J Nucl Med 2002; 43: (5 Suppl.) 10P-11P
102. LaCroix KJ, Tsui BM, Frey EC, et al. Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in 99mTc-sestamibi myocardial SPECT images. J Nucl Med 2000; 41: 502-13
103. Weber DA, Ivanovic M. Ultra-high-resolution imaging of small animals: implications for preclinical and research studies. J Nucl Cardiol 1999; 6: 332-44
104. Hirai T, Nohara R, Hosokawa R, et al. Evaulation of myocardial infarct size in rat heart by pinhole SPECT. J Nucl Cardiol 2000; 7: 107-11
105. Chapman JD, Schneider RF, Urbain JL, et al. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. Semin Radiat Oncol 2001; 11: 47-57
106. Hirai T, Nohara R, Ogoh S, et al. Serial evaluation of fatty acid metabolism in rats with myocardial infarction by pinhole SPECT. J Nucl Cardiol 2001; 8: 472-81
107. Habraken JBA, deBruin K, Shehata M, et al. Evaluation of high-resolution pinhole SPECT Using a small rotating animal. J Nucl Med 2001; 42: 1863-9
108. Strauss HW, Blankenberg FG. Small is beautiful: specialty imaging devices and the growth of nuclear cardiology. J Nucl Cardiol 2000; 7: 175-9